Taketo Makoto Mark, Sonoshita Masahiro
Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Biochim Biophys Acta. 2002 Dec 30;1585(2-3):72-6. doi: 10.1016/s1388-1981(02)00326-8.
Phospolipase A(2) (PLA(2)) is the esterase activity that cleaves the sn-2 ester bond in glycerophospholipids, releasing free fatty acids and lysophospholipids. The PLA(2) activity is found in a variety of enzymes which can be divided in several types based on their Ca(2+) dependence for their activity; Ca(2+)-dependent secretory phosholipases (sPLA(2)s) and cytosolic phospholipases (cPLA(2)s), and Ca(2+)-independent phospholipase A(2)s (iPLA(2)s). These enzymes also show diverse size and substrate specificity (i.e., in the fatty acid chain length and extent of saturation). Among the fatty acids released by PLA(2), arachidonic acid (AA) is of particular biological importance, because it is subsequently converted to prostanoids and leukotrienes by cyclooxygenases (COX) and lipoxygenases (LOX), respectively. Free AA may also stimulate apoptosis through activation of sphingomyelinase. Alternatively, it is suggested that oxidized metabolites generated from AA by LOX induce apoptosis. Although the precise mechanisms remain to be elucidated, changes are observed in glycerolipid metabolism during apoptotic processes. In some cells induced to undergo apoptosis, AA is released concomitant with loss of cell viability, caspase activation and DNA fragmentation. Such AA releases appear to be mediated by activation of cPLA(2) and/or iPLA(2). For example, tumor necrosis factor-alpha (TNF-alpha)-induced cell death is mediated by cPLA(2), whereas Fas-induced apoptosis appears to be mediated by iPLA(2). Some discrepancies among early experimental results were probably caused by differences in the experimental conditions such as the serum concentration, inhibitors used that are not necessarily specific to a single-type enzyme, or differential expression of each PLA(2) in cells employed in the experiments. Recent studies eliminated such problems, by carefully defining the experimental conditions, and using multiple inhibitors that show different specificities. Accordingly, more convincing data are available that demonstrate involvement of some PLA(2)s in the apoptotic processes. In addition to cPLA(2) and iPLA(2), sPLA(2)s were recently found to play roles in apoptosis. Moreover, new proteins that appear to control PLA(2)s are being discovered. Here, the roles of PLA(2)s in apoptosis are discussed by reviewing recent reports.
磷脂酶A(2)(PLA(2))是一种酯酶活性,可切割甘油磷脂中的sn-2酯键,释放游离脂肪酸和溶血磷脂。PLA(2)活性存在于多种酶中,这些酶可根据其活性对Ca(2+)的依赖性分为几种类型;Ca(2+)依赖性分泌型磷脂酶(sPLA(2)s)和胞质磷脂酶(cPLA(2)s),以及Ca(2+)非依赖性磷脂酶A(2)s(iPLA(2)s)。这些酶还表现出不同的大小和底物特异性(即脂肪酸链长度和饱和度程度)。在PLA(2)释放的脂肪酸中,花生四烯酸(AA)具有特别重要的生物学意义,因为它随后分别被环氧化酶(COX)和脂氧化酶(LOX)转化为前列腺素和白三烯。游离AA也可能通过鞘磷脂酶的激活刺激细胞凋亡。另外,有人提出LOX由AA产生的氧化代谢产物诱导细胞凋亡。虽然确切机制仍有待阐明,但在凋亡过程中观察到甘油脂质代谢发生变化。在一些诱导凋亡的细胞中,AA的释放与细胞活力丧失、半胱天冬酶激活和DNA片段化同时发生。这种AA释放似乎是由cPLA(2)和/或iPLA(2)的激活介导的。例如,肿瘤坏死因子-α(TNF-α)诱导的细胞死亡由cPLA(2)介导,而Fas诱导的细胞凋亡似乎由iPLA(2)介导。早期实验结果之间的一些差异可能是由实验条件的差异引起的,如血清浓度、使用的抑制剂不一定对单一类型的酶具有特异性,或实验中所用细胞中每种PLA(2)的差异表达。最近的研究通过仔细定义实验条件并使用具有不同特异性的多种抑制剂消除了这些问题。因此,有了更有说服力的数据,证明一些PLA(2)s参与了凋亡过程。除了cPLA(2)和iPLA(2)之外,最近发现sPLA(2)s在细胞凋亡中也起作用。此外,正在发现似乎控制PLA(2)s的新蛋白质。在此,通过综述最近的报告讨论PLA(2)s在细胞凋亡中的作用。